Seres Therapeutics, Inc.
MCRB
$19.44
$1.126.11%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -22.89% | 91.11% | -53.92% | -6.19% | -35.93% |
| Total Receivables | -57.95% | 33.51% | -- | -- | 150.75% |
| Inventory | -- | -- | -- | -- | 26.26% |
| Prepaid Expenses | -51.99% | -23.14% | -4.77% | -5.14% | 39.71% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -26.32% | 70.86% | -46.97% | -51.14% | -9.64% |
|
|
|||||
| Total Current Assets | -26.32% | 70.86% | -46.97% | -51.14% | -9.64% |
| Net Property, Plant & Equipment | -3.34% | -3.28% | -3.18% | -21.14% | -2.97% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 0.00% | 0.00% | -15.85% | -79.88% | 0.18% |
| Total Assets | -12.41% | 17.43% | -21.78% | -44.44% | -5.72% |
|
|
|||||
| Total Accounts Payable | 1.48% | -46.85% | -50.58% | 71.64% | -7.86% |
| Total Accrued Expenses | -6.61% | -41.97% | -39.50% | -59.07% | 7.92% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 4.74% | 4.32% | 3.93% | -9.23% | 4.10% |
| Total Finance Division Other Current Liabilities | -3.12% | -21.77% | -41.84% | -40.16% | 15.07% |
| Total Other Current Liabilities | -3.12% | -21.77% | -41.84% | -40.16% | 15.07% |
| Total Current Liabilities | -1.22% | -24.01% | -36.42% | -40.13% | 9.96% |
|
|
|||||
| Total Current Liabilities | -1.22% | -24.01% | -36.42% | -40.13% | 9.96% |
| Long-Term Debt | -- | -- | -- | -- | 0.48% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -3.16% | -2.97% | -2.70% | -15.52% | -2.33% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 3.11% | 3.10% | -61.09% | -95.13% | -0.08% |
| Total Liabilities | -2.52% | -9.77% | -18.60% | -62.13% | 1.95% |
|
|
|||||
| Common Stock & APIC | 0.23% | 0.40% | 0.56% | 2.30% | 0.58% |
| Retained Earnings | -2.10% | 3.34% | -1.62% | 8.44% | -3.23% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -34.71% | 266.11% | -42.37% | 127.47% | -45.76% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -34.71% | 266.11% | -42.37% | 127.47% | -45.76% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -34.71% | 266.11% | -42.37% | 127.47% | -45.76% |
|
|
|||||